Innovation
2 patent families — focus: Chemistry & metallurgy; filing pace slowing. Cited 12 times.
| Year | Filings |
|---|---|
| 2022 | 1 |
| 2023 | 2 |
Investor mix
3 investors on record; lead investors include Orbimed.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 33% |
| Private equity | 1 | 33% |
| Other / undisclosed | 1 | 33% |